WAM
WFA Asset Management’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28.2K | Buy |
733
+8
| +1% | +$308 | 0.02% | 127 |
|
2025
Q1 | $31.1K | Sell |
725
-22
| -3% | -$944 | 0.02% | 132 |
|
2024
Q4 | $25.3K | Buy |
747
+7
| +0.9% | +$237 | 0.01% | 149 |
|
2024
Q3 | $30.2K | Buy |
740
+7
| +1% | +$286 | 0.02% | 127 |
|
2024
Q2 | $28.2K | Buy |
733
+8
| +1% | +$308 | 0.02% | 128 |
|
2024
Q1 | $31.1K | Buy |
725
+6
| +0.8% | +$257 | 0.02% | 133 |
|
2023
Q4 | $26.6K | Hold |
719
| – | – | 0.01% | 130 |
|
2023
Q3 | $26.1K | Hold |
719
| – | – | 0.02% | 128 |
|
2023
Q2 | $25.6K | Buy |
719
+165
| +30% | +$5.88K | 0.02% | 136 |
|
2023
Q1 | $19.7K | Hold |
554
| – | – | 0.01% | 143 |
|
2022
Q4 | $19.5K | Hold |
554
| – | – | 0.01% | 127 |
|
2022
Q3 | $16.3K | Sell |
554
-134
| -19% | -$3.94K | 0.01% | 133 |
|
2022
Q2 | $29.9K | Buy |
688
+9
| +1% | +$392 | 0.02% | 108 |
|
2022
Q1 | $29.6K | Buy |
679
+8
| +1% | +$348 | 0.02% | 113 |
|
2021
Q4 | $29.6K | Buy |
+671
| New | +$29.6K | 0.02% | 107 |
|